glucagon vs glp-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 metabolite GLP-1(9–36) is a

diabetes.org/newsroom/press-releases/cagrisema-demonstrates-significant-weight-loss-adults-obesity CagriSema Demonstrates Significant Weight Loss in Adults

There has been a concern that high doses can raise the level of a substance called TMAO (linked in some studies to a greater risk of heart disease), but the evidence is not clear-cut, and the doses used in most studies (about 2,000 mg a day) are considered safe

There is no human trial that sets a timeline, so reports are anecdotal and drawn from animal research

Optimize Meal Timing and Sequence Eating protein and fiber before carbohydrates amplifies GLP-1 release